Cargando…
Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platform
Real world data (RWD) are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources; real-world evidence (RWE) generated by RWD analyses can become an important component of drug development programs and, potentially, regulatory decision-...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638071/ https://www.ncbi.nlm.nih.gov/pubmed/34868623 http://dx.doi.org/10.1177/20552076211059975 |
_version_ | 1784608878443364352 |
---|---|
author | Bourla, Ariel B. Meropol, Neal J. |
author_facet | Bourla, Ariel B. Meropol, Neal J. |
author_sort | Bourla, Ariel B. |
collection | PubMed |
description | Real world data (RWD) are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources; real-world evidence (RWE) generated by RWD analyses can become an important component of drug development programs and, potentially, regulatory decision-making. As a RWD source, electronic health records (EHRs) can now provide patient-level data at unparalleled depth and granularity. We propose a RWE generation framework that could maximize the synergy between RWD and prospective clinical trials by capitalizing on an emerging data curation infrastructure that may be applied to both retrospective and prospective research. In this platform, centralized data collection and monitoring could be enabled via routine EHR use, and seamlessly integrated with select intentional data capture during prospective study periods. By bridging the divide between routine care and clinical research, this integrated platform aggregates retrospective and prospective data, collected both routinely and intentionally. This approach makes clinical trial participation more available to patients, increasing the potential depth of data, representativeness and efficiency of clinical research. |
format | Online Article Text |
id | pubmed-8638071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-86380712021-12-03 Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platform Bourla, Ariel B. Meropol, Neal J. Digit Health Brief Communication Real world data (RWD) are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources; real-world evidence (RWE) generated by RWD analyses can become an important component of drug development programs and, potentially, regulatory decision-making. As a RWD source, electronic health records (EHRs) can now provide patient-level data at unparalleled depth and granularity. We propose a RWE generation framework that could maximize the synergy between RWD and prospective clinical trials by capitalizing on an emerging data curation infrastructure that may be applied to both retrospective and prospective research. In this platform, centralized data collection and monitoring could be enabled via routine EHR use, and seamlessly integrated with select intentional data capture during prospective study periods. By bridging the divide between routine care and clinical research, this integrated platform aggregates retrospective and prospective data, collected both routinely and intentionally. This approach makes clinical trial participation more available to patients, increasing the potential depth of data, representativeness and efficiency of clinical research. SAGE Publications 2021-11-25 /pmc/articles/PMC8638071/ /pubmed/34868623 http://dx.doi.org/10.1177/20552076211059975 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Brief Communication Bourla, Ariel B. Meropol, Neal J. Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platform |
title | Bridging the divide between clinical research and clinical care in oncology:
An integrated real-world evidence generation platform |
title_full | Bridging the divide between clinical research and clinical care in oncology:
An integrated real-world evidence generation platform |
title_fullStr | Bridging the divide between clinical research and clinical care in oncology:
An integrated real-world evidence generation platform |
title_full_unstemmed | Bridging the divide between clinical research and clinical care in oncology:
An integrated real-world evidence generation platform |
title_short | Bridging the divide between clinical research and clinical care in oncology:
An integrated real-world evidence generation platform |
title_sort | bridging the divide between clinical research and clinical care in oncology:
an integrated real-world evidence generation platform |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638071/ https://www.ncbi.nlm.nih.gov/pubmed/34868623 http://dx.doi.org/10.1177/20552076211059975 |
work_keys_str_mv | AT bourlaarielb bridgingthedividebetweenclinicalresearchandclinicalcareinoncologyanintegratedrealworldevidencegenerationplatform AT meropolnealj bridgingthedividebetweenclinicalresearchandclinicalcareinoncologyanintegratedrealworldevidencegenerationplatform |